BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23086090)

  • 1. Statins for the prevention of venous thromboembolism? a narrative review.
    Sehdev A; Wanner N; Pendleton RC
    Hosp Pract (1995); 2012 Aug; 40(3):13-8. PubMed ID: 23086090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and venous thromboembolism: do they represent a viable therapeutic agent?
    Kunutsor SK; Whitehouse MR; Blom AW; Laukkanen JA
    Expert Rev Cardiovasc Ther; 2017 Aug; 15(8):629-637. PubMed ID: 28724320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism prophylaxis for the medical patient: where do we stand?
    Yavin Y; Cohen AT
    Semin Respir Crit Care Med; 2008 Feb; 29(1):75-82. PubMed ID: 18302089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Venous thromboembolism prophylaxis in internal medicine].
    Malý J; Widimský J; Dulícek P
    Vnitr Lek; 2009 Mar; 55(3):190-5. PubMed ID: 19378845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Statins for Prevention of Venous Thromboembolism.
    Chaffey P; Thompson M; Pai AD; Tafreshi AR; Tafreshi J; Pai RG
    Am J Cardiol; 2018 Jun; 121(11):1436-1440. PubMed ID: 29576234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboprophylaxis in orthopedic surgery: how long is long enough?
    Muntz J
    Am J Orthop (Belle Mead NJ); 2009 Aug; 38(8):394-401. PubMed ID: 19809604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
    Cohen AT; Nandini B; Wills JO; Ota S
    Thromb Res; 2010 Apr; 125 Suppl 2():S21-9. PubMed ID: 20434000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
    Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
    Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins, aspirin and risk of thromboembolic events in ovarian cancer patients.
    Shai A; Rennert HS; Rennert G; Sagi S; Leviov M; Lavie O
    Gynecol Oncol; 2014 May; 133(2):304-8. PubMed ID: 24631448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
    Quinlan DJ; Eriksson BI
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):171-82. PubMed ID: 23953905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use and the prevention of venous thromboembolism: a meta-analysis.
    Agarwal V; Phung OJ; Tongbram V; Bhardwaj A; Coleman CI
    Int J Clin Pract; 2010 Sep; 64(10):1375-83. PubMed ID: 20716146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of venous thromboembolism in surgery, laparoscopic surgery and urology].
    Gumulec J; Zänger M; Procházka V; Urbanec R; Klement P
    Vnitr Lek; 2009 Mar; 55(3):196-203. PubMed ID: 19378846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins in the prevention of venous thromboembolism: a meta-analysis of observational studies.
    Pai M; Evans NS; Shah SJ; Green D; Cook D; Crowther MA
    Thromb Res; 2011 Nov; 128(5):422-30. PubMed ID: 21641019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of venous thromboembolism: focus on mechanical prophylaxis.
    Lippi G; Favaloro EJ; Cervellin G
    Semin Thromb Hemost; 2011 Apr; 37(3):237-51. PubMed ID: 21455858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivaroxaban: an oral factor Xa inhibitor.
    Thomas TF; Ganetsky V; Spinler SA
    Clin Ther; 2013 Jan; 35(1):4-27. PubMed ID: 23328267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
    Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
    Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of heparin anticoagulants to ultra-low-molecular-weight heparins: a review of pharmacologic and clinical differences and applications in patients with cancer.
    Walenga JM; Lyman GH
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):1-18. PubMed ID: 23849978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.